News | tctmd.com

More Evidence That the MitraClip Might Be Useful in the Tricuspid Valve

Data from the TriValve registry show that treating tricuspid regurgitation with the MitraClip is tied to improved clinical outcomes.

By Todd Neale

September 24, 2018

More Evidence That the MitraClip Might Be Useful in the Tricuspid Valve

Off Script: Opacity, Transparency, and Magic Buttons in the Cath Lab

We are so focused on ‘seeing’ in procedures, we sometimes fail to fully understand the implications of delivering ionizing radiation on this scale.

By Kwan S. Lee

September 24, 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

ACS patients may have a lower risk of major bleeding if treated with ticagrelor, but this finding is hypothesis-generating only, say experts

By Michael O'Riordan

September 24, 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Experts say there are now enough data to move forward with a randomized trial in this field to determine how NIRS can best guide treatment

By Yael L. Maxwell

September 24, 2018

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Given the body of evidence supporting IVUS-guided PCI, physicians here questioned why operators are so resistant to change.

By Lucy Hicks

September 24, 2018

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Slow enrollment led to a premature end to the study, making it difficult to draw firm conclusions.

By Todd Neale

September 24, 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Editor's Corner

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

Today’s late breakers included studies of IVUS, near infrared spectroscopy, and the prickly problem of anticoagulation post-PCI in A-fib patients.

By Shelley Wood

September 24, 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

The trial showed superior primary patency results with Eluvia versus Zilver PTX.

By Todd Neale

September 24, 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

In the second big trial surprise of the week, high-dose, prescription fish oil appears to have significantly reduced the risk of CV events.

By Shelley Wood

September 24, 2018

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

Editor's Corner

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

There had been rumbles leading up to TCTMD that COAPT would be positive, but the response of the audience suggests people hadn’t expected this.

By Shelley Wood

September 23, 2018

Off Script: A Monumental, First-World Victory vs an Enduring First-World Failure

It’s a historic day for interventional cardiology, but the fruits of innovation remain out of reach for much of the world. Not in every domain, however.

By Kwan S. Lee

September 23, 2018